Robin Newman

Robin Newman is a young and accomplished engineering professional in the Novel Therapeutics Industry. With expertise in start-up ventures, tech transfer, and clinical batch campaign readiness, she brings a wealth of experience to her role. Robin earned a B.S. in Chemical Engineering from Rensselaer Polytechnic Institute. Currently, she serves as a CQV Lead/Project Manager at Core Group Services, where she collaborates with a CDMO client to implement cutting-edge AAV platform technology. Beyond her technical prowess, Robin is deeply passionate about patient advocacy, driving her desire to make a significant impact in the field. Her ultimate goal is to become a Novel Therapeutics SME/Principal Engineer, leveraging her expertise to shape the future of the industry.